Skip to main content

Table 3 Description of the 11 patients fulfilling only ACR/EULAR criteria

From: Comparison of 2002 AECG and 2016 ACR/EULAR classification criteria and added value of salivary gland ultrasonography in a patient cohort with suspected primary Sjögren’s syndrome

Pt.

Age

Dura-tiona

Eyeb

Mouthc

ESSDAI

ESSDAI domainsd

Other AID

Low UWSF

Schirmer

VB ≥ 4

SGB

ANA

SSA

SSB

RF

IgG

SGUS

Diage

1

51

1

0

1

4

A, B

0

1

0

 

1

0

0

0

1

23.7

1

1

2

38

2

0

1

2

A

0

0

1

 

1

320

0

0

1

11.5

0

0

3

80

12

0

1

0

/

Thyroiditis

1

0

 

1

320

0

0

0

12.1

0

1

4

54

1

0

0

5

A, G, B

0

0

0

 

1

1 280

1

0

0

17.5

1

1

5

19

6

0

0

10

PNS

0

0

0

 

1

320

1

0

1

12.5

1

1

6

61

5

1

0

2

A

Thyroiditis

0

0

1

1

0

0

0

1

9.5

1

0

7

64

23

1

0

6

A, H, B

AI hepatitis

0

0

0

1

320

1

0

0

15.8

/

1

8

57

4

0

1

10

A, H, B

AI hepatitis

0

1

1

0

1280

1

1

1

20.8

/

1

9

67

2

0

1

2

A

0

0

1

0

1

320

0

0

0

8

0

0

10

42

1

0

0

5

A, B

0

0

0

 

1

320

1

0

0

19

0

1

11

56

3

0

1

4

L

Thyroiditis

0

1

 

1

160

0

0

0

9.7

0

0

  1. Pt patient, ESSDAI EULAR pSS Disease Activity Index, AID autoimmune disease, UWSF unstimulated whole salivary flow, VB van Bijsterveld score, SGB salivary gland biopsy, ANA anti-nuclear antibodies, SSA Anti-Sjögren's-syndrome-related antigen A RF rheumatoid factors, SGUS salivary gland ultrasonography
  2. aSymptom duration in years
  3. bSubjective ocular dryness
  4. cSubjective oral dryness
  5. d A articular, P pulmonary, PNS peripheral nervous system, R renal, G glandular, C cutaneous, L lymphadenopathy, H hematological, B biological
  6. eDiagnosis of primary Sjögren’s syndrome by the physician